Therapy-related myeloid leukemia

Hematology/Oncology Clinics of North America

Volumn 10, Issue 2, 1996, Pages 293-320

  Thirman, M J ^a   Larson, R A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANDROGEN; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BIMOLANE; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GYRASE INHIBITOR; LOMUSTINE; MELPHALAN; METHOTREXATE; MITOLACTOL; MITOXANTRONE; PREDNISONE; PROCARBAZINE; SEMUSTINE; TENIPOSIDE; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VINCRISTINE SULFATE; ZORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CHROMOSOME 11Q; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME TRANSLOCATION 11; CLINICAL FEATURE; DRUG THERAPY; HODGKIN DISEASE; HUMAN; LEUKEMOGENESIS; MYELOID LEUKEMIA; ONCOGENE RAS; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; REVIEW; RISK FACTOR; SECOND CANCER; WHOLE BODY RADIATION;

EID: 0029870455     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70340-3     Document Type: Article

References (139)

1. J. Abrams M. Smith Acute myeloid leukemia following doxorubicin and cyclophosphamide: Increased risk for dose-intensive regimens? Physician Data Query July 29, 1994
2. K.S. Albain M.M. Le Beau R. Ullirsh Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation Genes Chromosom Cancer 2 1990 53 58
3. J.-M. Andrieu N. Ifrah C. Payen Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease J Clin Oncol 8 1990 1148 1154
4. F.R. Appelbaum J. Barrall R. Storb Bone marrow transplantation for patients with myelodysplasia: Pretreatment variables and outcome Ann Intern Med 112 1990 590 597
5. E. Archimbaud C. Charrin D. Guyotat Acute leukaemia with t(4;11) in patients previously exposed to carcinogens Br J Haematol 69 1988 467
6. D.C. Arthur C.D. Bloomfield Banded chromosome analysis in patients with treatment-associated acute nonlymphocytic leukemia Cancer Genet Cytogenet 12 1984 189 199
7. K.K. Ballen J.H. Antin Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes Hematol Oncol Clin North Am 7 1993 477 493
8. J.M. Bennett W.C. Moloney M.H. Greene Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents Hematol Pathol 1 1987 99 104
9. O.A. Bernard M. Mauchauffe C. Mecucci A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL Oncogene 9 1994 1039 1045
10. M. Bessho Y. Itoh S. Kataumi A hematological remission by clonal hematopoiesis after treatment with recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin in a patient with therapy-related myelodysplastic syndrome Leuk Res 16 1992 123 131
11. M. Bhavnani S.A. Azzawi J.A. Yin G.S. Lucas Therapy-related acute promyelocytic leukaemia Br J Haematol 86 1994 231 232
12. D.W. Blayney D.L. Longo R.C. Young Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease N Engl J Med 316 1987 710 714
13. D. Boice Jr M.H. Greene J.Y. Killen Jr Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU) N Engl J Med 309 1983 1079 1084
14. J.-F. Boivin G.B. Hutchison M. Lyden Secondary primary cancers following treatment of Hodgkin's disease J Natl Cancer Inst 72 1984 233 241
15. M. Bower P. Parry B. Gibbons Human trithorax gene rearrangements in therapy-related acute leukaemia after etoposide treatment Leukemia 8 1994 226 229
16. E. Brusamolino G. Papa P. Valagussa Treatment-related leukemia in Hodgkin's disease: A multi-institution study on 75 cases Hematol Oncol 5 1987 83 98
17. N.J. Bunin J.T. Casper C. Chitambar Partially matched bone marrow transplantation in patients with myelodysplastic syndromes J Clin Oncol 6 1988 1851 1855
18. A.E. Butler J.W. Vardiman H.M. Golomb Ultrastructural characterization of de novo and secondary leukemias Virchows Arch [B] 39 1982 239 257
19. E. Cadman R. Capizzi J. Bertino Acute nonlymphocytic leukemia Cancer 40 1977 1280
20. N.J. Chao A.P. Nademanee G.P. Long Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease J Clin Oncol 9 1991 1575 1579
21. M.P. Coleman C.M.J. Bell P. Fraser Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis. A population-based cohort study Br J Cancer 56 1987 349
22. C.A. Coltman Jr D.O. Dixon Second malignancies complicating Hodgkin's disease: A Southwest Oncology Group 10-year follow up Cancer Treat Rep 66 1982 1023 1033
23. J. Corral A. Forster S. Thompson Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocations Proc Natl Acad Sci USA 90 1993 8538
24. J. Cortes S. O'Brien H. Kantarjian Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes Leukemia 8 1994 2174 2178
25. R.E. Curtis Jr J.D. Boice W.C. Moloney Leukemia following chemotherapy for breast cancer Cancer Res 50 1990 2741 2746
26. R.E. Curtis J.D. Boice Jr M. Stovall Leukemia risk following radiotherapy for breast cancer J Clin Oncol 7 1989 21 29
27. R.E. Curtis J.D. Boice M. Stovall Risk of leukemia after chemotherapy and radiation treatment for breast cancer N Engl J Med 326 1992 1745 1751
28. D.L. Darrington J.M. Vose J.R. Anderson Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 12 1994 2527 2534
29. A. De Gramont C. Louvet M. Krulik Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy Cancer 58 1986 630 634
30. L. Detourmignies S. Castaigne A.M. Stoppa Therapy-related acute promyelocytic leukemia: A report on 16 cases J Clin Oncol 10 1992 1430 1435
31. S. Devereux G. Selassie Vaughan Hudson G. Leukaemia complicating treatment for Hodgkin's disease: The experience of the British National Lymphoma Investigation Br Med J 301 1990 1077
32. R. DeVore J. Whitlock J.D. Hainsworth Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q Ann Intern Med 110 1989 740 742
33. T. De Witte P. Muus B. De Pauw C. Haanen Intensive antileukemia treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia Cancer 66 1990 831 837
34. T. De Witte F. Zwaan J. Hermans Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: A survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Br J Haematol 74 1990 151 155
35. S.F. Duane B.A. Peterson C.D. Bloomfield Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy Med Pediatr Oncol 13 1985 207 213
36. G. Falkson R.S. Gelman R. Dreicer syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer J Clin Oncol 7 1989 1252 1259
37. P. Fenaux J.P. Jouet F. Bauters Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: Good response to antileukemic drugs J Clin Oncol 5 1987 1304 1305
38. P. Fenaux D. Lucidarme J.L. La i1 Favorable cytogenetic abnormalities in secondary leukemia Cancer 63 1989 2505 2508
39. B. Fisher H. Rockette E.R. Fisher Leukemia in breast cancer patients following adjuvant or postoperative radiation: The NSABP experience J Clin Oncol 3 1985 1630 1658
40. Fourth International Workshop on Chromosomes in Leukemia 1982 Secondary leukemias associated with neoplasia: Treated and untreated Cancer Genet Cytogenet 11 1984 319 321
41. R.B. Geller G.B. Vogelsang J.R. Wingard Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease J Clin Oncol 6 1988 1558 1561
42. S.L. Gerson Molecular epidemiology of leukemias Curr Opin Oncol 5 1 1993 136 144
43. A.S. Glicksman T.F. Pajak A. Gottlieb Second malignant neoplasms in patients successfully treated for Hodgkin's disease: A Cancer and Leukemia Group B Study Cancer Treat Rep 66 1982 1035 1044
44. W.J. Gradishar M.M. Le Beau R. O'Laughlin Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related Blood 80 1992 2463 2470
45. M.H. Greene J.D. Boice Jr B.E. Greer Acute non-lymphocytic leukemia after therapy with alkylating agents for ovarian cancer N Engl J Med 307 1982 1416 1421
46. M.H. Greene J.D. Boice T.A. Strike Carmustine as a cause of acute nonlymph2251 ocytic leukemia N Engl J Med 313 1985 579
47. M.H. Greene E.L. Harris D.M. Gershenson Melphalan may be a more potent leukemogen than Ann Intern Med 105 1986 360 367
48. M.H. Greene R.C. Young J.M. Merrill Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma Cancer Res 43 1983 1891 1898
49. Groupe Francais de Cytogeènètique Heèmatologique Acute leukemia treated with intensive chemotherapy in patients with a history of previous chemo- and/or radiotherapy: Prognostic significance of karyotype and preceding myelodysplastic syndrome Leukemia 8 1994 87 91
50. Groupe Francais de Cytogènètique Hèmatologique: Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: A cooperative study Cancer Genet Cytogenet 12 1984 95 104
51. Y. Gu T. Nakamura H. Alder The t(14;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene Cell 71 1992 701 708
52. M. Henry-Amar D.M. Aeppli J. Anderson Workshop statistical report. Part IX: Study of second cancer risk R. Somers M. Henry-Amar J.H. Meerwaldt P. Carde Treatment Strategy in Hodgkin's Disease. Colloque Inserm vol 196 1990 Inserm/John Libbey Eurotext London 355
53. M. Henry-Amar P.-Y. Dietrich Acute leukemia after the treatment of Hodgkin's disease Hematol Oncol Clin North Am 7 1993 369 387
54. C.F. Hoyle M. de Bastos K. Wheatley AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: Results from the MRC's 9th AML trial Br J Haematol 72 1989 45 53
55. S.P. Hunger D.C. Tkachuk M.D. Amylon HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities Blood 81 1993 3197 3203
56. Ionizing and Effects. A Report of the United Nations Scientific Committee on the Effects of Atomic Radiation 1972 United Nations New York
57. A. Iurlo C. Mecucci A. Van Orshoven Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome Cancer Genet Cytogenet 43 1989 227 241
58. P. Jonveaux J. Hillion O. Bernard Distinct MLL gene rearrangements associated with successive acute monocytic and lymphoblastic leukemias in the same patient Leukemia 8 1994 2224 2227
59. J.M. Kaldor N.E. Day P. Band Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries Int J Cancer 39 1987 571 585
60. J.M. Kaldor N.E. Day E.A. Clarke Leukemia following Hodgkin's disease N Engl J Med 322 1990 7
61. H.M. Kantarjian E.H. Estey M.J. Keating Treatment of therapy-related leukemia and myelodysplastic syndrome Hematol Oncol Clin North Am 7 1993 81 107
62. H.M. Kantarjian M.J. Keating R.S. Walters leukemia and myelodysplastic syndrome: Clinical, cytogenetic, and prognostic features J Clin Oncol 4 1986 1748 1757
63. H.P. Koeffler J.D. Rowley Therapy-related acute nonlymphocytic leukemia P.H. Wiernick G.P. Canellos R.A. Kyle C.A. Schiffer Neoplastic Diseases of the Blood 1984 Churchill Livingstone New York 357 381
64. J.L. Lai M. Zandecki P. Fenaux Translocations (5;17) and (7;17) in patients with de novo or syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huèt anomaly and small vacuolated granulocytes Cancer Genet Cytogenet 46 1990 173 183
65. R.A. Larson M.M. Le Beau M.J. Ratain Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia Blood 79 1992 1892 1893
66. R.A. Larson M. Wernli M.M. Le Beau Short remission durations in therapyrelated leukemia despite cytogenetic complete response to high-dose cytarabine Blood 72 1988 1333 1339
67. M.M. Le Beau K.S. Albain R.A. Larson Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7 J Clin Oncol 4 1986 325 345
68. M.M. Le Beau R.S. Lemons R. Espinosa III Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q) Blood 73 1989 647 650
69. E.G. Levine C.D. Bloomfield Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure Semin Oncol 19 1992 471
70. J.B. Little Cellular, molecular, and carcinogenic effects of radiation Hematol Oncol Clin North Am 7 1993 337 352
71. G. Longmore E.C. Guinan H.J. Weinstein Bone marrow transplantation for myelodysplasia and secondary acute leukemia J Clin Oncol 8 1990 1707 1714
72. N.R. McCabe R.C. Burnett H.J. Gill Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations Proc Natl Acad Sci USA 89 1992 11794 11798
73. A.T. Meadows E. Baum F. Fossati-Bellani Second malignant neoplasms in children: An update from the Late Effects Study Group J Clin Oncol 3 1985 532 538
74. A.T. Meadows A.C. Obringer O. Marrero Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors Med Pediatr Oncol 17 1989 477
75. S.D. Michels R.W. McKenna D.C. Arthur acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphologic study of 65 cases Blood 65 1985 1364 1372
76. J.S. Miller D.C. Arthur C.E. Litz Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy Blood 83 1994 3780 3786
77. W.C. Moloney Radiogenic leukemia revisited Blood 70 1987 905 908
78. T. Nakamura H. Alder Y. Gu Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs Proc Natl Acad Sci USA 90 1993 4631
79. W.L. Neuman C.M. Rubin R.B. Rios Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders Blood 79 1992 1501 1510 Nucifora G, Birn DJ, Espinosa R III, et al: Involvement of the AML1 gene in the t(3;21) in leukemia and in chronic myeloid leukemia in blast crisis. Blood
80. 1993.
81. G. Nucifora J.D. Rowley AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia Blood 86 1995 1 14
82. J. Pedersen-Bjergaard G. Daugaard S.W. Hansen Increased risk of and leukaemia after etoposide, cisplatin and bleomycin for germ cell tumours Lancet 338 1991 359
83. J. Pedersen-Bjergaard J. Ersboll H. Mygind Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphoma Ann Intern Med 103 1985 195 200
84. J. Pedersen-Bjergaard J.W.G. Janssen J. Lyons Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents Cancer Res 48 1988 1812 1817
85. J. Pedersen-Bjergaard B. Johansson P. Philip Translocation (3;21)(q26;q22) in therapyrelated following drugs targeting DNA-topoisomerase II combined with alkylating agents, and in disorders undergoing spontaneous leukemic transformation Cancer Genet Cytogenet 76 1994 50 55
86. J. Pedersen-Bjergaard S.O. Larsen Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease N Engl J Med 307 1982 965 971
87. J. Pedersen-Bjergaard P. Philip Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II Blood 78 1991 1147 1148
88. J. Pedersen-Bjergaard P. Philip Two different classes of therapy-related and de-novo acute myeloid leukemia? Cancer Genet Cytogenet 55 1991 119 124
89. J. Pedersen-Bjergaard P. Philip S.O. Larsen Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series Leukemia 7 1993 1975 1986
90. J. Pedersen-Bjergaard P. Philip B.T. Mortensen Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing Blood 57 1981 712 723
91. J. Pedersen-Bjergaard P. Philip V. Ravn Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11)(p21;q23) or a normal karyotype: A separate entity J Clin Oncol 6 1988 395 397
92. J. Pedersen-Bjergaard P. Philip N. Tinggaard Pedersen Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases Cancer 54 1984 452 462
93. J. Pedersen-Bjergaard J.D. Rowley The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation Blood 83 1994 2780 2786
94. J. Pedersen-Bjergaard T.C. Sigsgaard D. Nielsen Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer J Clin Oncol 10 1992 1444 1451
95. J. Pedersen-Bjergaard L. Sprecht S.O. Larsen Risk of therapy-related leukemia and preleukemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy Lancet 2 1987 83
96. R. Prasad Y. Gu H. Alder Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocations Cancer Res 53 1993 5624
97. H.D. Preisler A.P. Early A. Raza Therapy of secondary acute nonlymphocytic leukemia with cytarabine N Engl J Med 308 1983 21 23
98. C.-H. Pui F.G. Behm S.C. Raimondi Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia N Engl J Med 321 1989 136 142
99. C.H. Pui S.C. Raimondi F.G. Behm Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia Blood 68 1986 1306 1310
100. C.H. Pui R. Ribeiro M.L. Hancock Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia N Engl J Med 325 1991 1682 1687
101. B. Quesnel H. Kantarjian J.P. Bjergaard Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): A report on 25 cases and review of the literature J Clin Oncol 11 1993 2370 2379
102. M.J. Ratain L.S. Kaminer J.D. Bitran Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung Blood 70 1987 1412
103. M.J. Ratain J.D. Rowley Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes Ann Oncol 3 2 1992 107 111
104. R.R. Reimer R. Hoover J.F. Fraumeni Acute leukemia after therapy of ovarian cancer N Engl J Med 297 1977 177
105. B. Rosenbloom R. Schreck H.P. Koeffler Therapy-related myelodysplastic syndromes Hematol Oncol Clin North Am 6 1992 707 722
106. J.D. Rowley M.O. Diaz R. Espinosa III Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome Proc Natl Acad Sci USA 87 1990 9358 9362
107. J.D. Rowley H.M. Golomb J.W. Vardiman Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease Blood 58 1981 759 767
108. C.M. Rubin D.C. Arthur W.G. Woods Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: Correlation between chromosomal abnormalities and prior therapy Blood 78 1991 2982 2988
109. C.M. Rubin R.A. Larson J. Anastasi A recurring chromosomal abnormality in therapy-related syndrome and acute myeloid leukemia Blood 76 1990 2594 2598
110. B.L. Samuels R.A. Larson M.M. Le Beau Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo Leukemia 2 1988 79 83
111. M. Sargur C.D. Buckner F.R. Appelbaum Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease J Clin Oncol 5 1987 731 734
112. L.M. Secker-Walker E.L. Stewart A. Todd Acute leukaemia with t(4;11) follows neuroblastoma: A late effect of treatment? Med Pediatr Oncol 13 1985 48
113. M.A. Smith L. Rubinstein R.S. Ungerleider acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks Med Pediatr Oncol 23 1994 86 98
114. R.T. Spielberger J.I. Dickstein M.M. LeBeau Acute myeloid leukemia following interferon-alfa treatment of hairy cell leukemia Br J Haematol 83 1993 519 520
115. R.M. Stone Myelodysplastic syndrome after autologous transplantation for lymphoma: The price of progress? Blood 83 1994 3437 3440
116. R.M. Stone D. Neuberg R. Soiffer syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma J Clin Oncol 12 1994 2535 2542
117. H.J. Super N.R. McCabe M.J. Thirman of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II Blood 82 1993 3705 3711
118. M. Thangavelu M.A. Bitter R.A. Larson A new recurring abnormality in malignant myeloid disorders Cancer Genet Cytogenet 37 1989 1 8
119. M.J. Thirman H.J. Gill R.C. Burnett Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations N Engl J Med 329 1993 909 914
120. M.J. Thirman D.A. Levitan H. Kobayashi Cloning of ELL , a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia Proc Natl Acad Sci USA 91 1994 12110 12114
121. D.C. Tkachuk S. Kohler M.L. Cleary Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias Cell 71 1992 691 700
122. S.T. Traweek M.L. Slovak A.P. Nademanee Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma Blood 84 1994 957 963
123. M.A. Tucker C.N. Coleman R.S. Cox Risk of second cancers after treatment for Hodgkin's disease N Engl J Med 318 1988 76
124. M.A. Tucker A.T. Meadows J.D. Boice Jr Leukemia after therapy with alkylating agents for childhood cancer J Natl Cancer Inst 78 1987 459 464
125. S. Vadhan-Raj H.E. Broxmeyer G. Spitzer Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome Blood 74 1989 1491 1498
126. P. Valagussa A. Santoro F. Fossati-Bellani Second acute leukemia and other malignancies following treatment for Hodgkin's disease J Clin Oncol 4 1986 830 837
127. P. Valagussa G. Tancini G. Bonadonna Second malignancies after CMF for resectable breast cancer J Clin Oncol 5 1987 1138 1142
128. E.A. Vandenberghe C. Mecucci A. Delannoy Deletion of 5q by t(5;17) in myelodysplastic syndrome Cancer Genet Cytogenet 48 1990 49 52
129. J.W. van der Velden W.L.J. van Putten V.F. Guinee Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease Int J Cancer 42 1988 252 255
130. F.E. Van Leeuwen R. Somers B.G. Taal Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease J Clin Oncol 7 1989 1046 1058
131. J.W. Vardiman H.M. Golomb J.D. Rowley Acute nonlymphocytic leukemia in malignant lymphoma Cancer 42 1978 229 242
132. W.P. Vaughan J.E. Karp P.J. Burke Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy J Clin Oncol 1 1983 204 207
133. H.J. Weh H. Kabisch G. Landbeck (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2-1/2 years after successful chemotherapy for J Clin Oncol 4 1986 1518 1520
134. C.A. Westbrook M.J. Keinanen Myeloid malignancies and chromosome 5 deletions Baillieres Clin Haematol 5 1992 931 942
135. J. Whang-Peng R.C. Young E.C. Lee Cytogenetic studies in patients with secondary syndrome after different treatment modalities Blood 71 1988 403 414
136. Y. Xue D. Lu Y. Guo B. Lin Specific chromosomal translocations and therapy-related leukemia induced by bimolane therapy for psoriasis Leuk Res 16 1992 1113 1123
137. Zhang MG, Wang XY, Gao LS:
138. cases of acute leukemia caused by bimolane Chung Hua Nei Ko Tsa Chih 32 1993 668 672
139. S. Ziemin-van der Poel N.R. McCabe H.J. Gill Identification of a gene ( MLL ) which spans the breakpoint in 11q23 translocations associated with human leukemias Proc Natl Acad Sci USA 88 1991 10735 10739